Streptococcus pneumoniae antibody titres in patients with primary antibody deficiency receiving intravenous immunoglobulin (IVIG) compared to subcutaneous immunoglobulin (SCIG).

about

Pneumococcal Antibody Titers: A Comparison of Patients Receiving Intravenous Immunoglobulin Versus Subcutaneous Immunoglobulin.Functional antibodies to Haemophilus influenzae type B, Neisseria meningitidis, and Streptococcus pneumoniae contained in intravenous immunoglobulin products.

P2860

Q37695737-849F53FA-AE9C-4FA2-B7A3-CB31887D8256 Q40489334-3F8B5FE1-87D4-4E69-8864-AF08D852982A

P2860

Streptococcus pneumoniae antibody titres in patients with primary antibody deficiency receiving intravenous immunoglobulin (IVIG) compared to subcutaneous immunoglobulin (SCIG).

Item

http://www.wikidata.org/entity/Q41078743

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Streptococcus pneumoniae antib ...... taneous immunoglobulin (SCIG).

@en

type

Item

label

Streptococcus pneumoniae antib ...... taneous immunoglobulin (SCIG).

@en

prefLabel

Streptococcus pneumoniae antib ...... taneous immunoglobulin (SCIG).

@en

P1476

Streptococcus pneumoniae antib ...... taneous immunoglobulin (SCIG).

@en

P2093

A P Knutsen

http://www.w3.org/2001/XMLSchema#string

C Caruthers

http://www.w3.org/2001/XMLSchema#string

J Rodrigues

http://www.w3.org/2001/XMLSchema#string

L E Leiva

http://www.w3.org/2001/XMLSchema#string

R U Sorensen

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of antibodies to capsular polysaccharide antigens of Haemophilus influenzae type b and Streptococcus pneumoniae in human immune globulin intravenous preparations

Optimizing immunoglobulin treatment for patients with primary immunodeficiency disease to prevent pneumonia and infection incidence: review of the current data.

Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies.

Evaluation of correlation between dose and clinical outcomes in subcutaneous immunoglobulin replacement therapy.

IgG levels against 13-valent pneumococcal conjugate vaccine serotypes in non pneumococcal conjugate vaccine immunized healthy Japanese and intravenous immunoglobulin preparations.

Use and interpretation of diagnostic vaccination in primary immunodeficiency: a working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology.

Consistency of protective antibody levels across lots of intravenous immunoglobulin preparations.

Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years.

P304

51-56

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CEI.12665

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

182

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26230522

http://www.w3.org/2001/XMLSchema#string

P932

4578508

http://www.w3.org/2001/XMLSchema#string

Streptococcus pneumoniae antibody titres in patients with primary antibody deficiency receiving intravenous immunoglobulin (IVIG) compared to subcutaneous immunoglobulin (SCIG).

about

P2860

P2860

Streptococcus pneumoniae antibody titres in patients with primary antibody deficiency receiving intravenous immunoglobulin (IVIG) compared to subcutaneous immunoglobulin (SCIG).

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932